Understanding the long-term outcomes is critical for groups who are considering adding these therapies to coverage for weight loss so they can assess whether covering the cost of these therapies for their employees is affordable when long-term adherence and reduction in medical spend has yet to be established. Blue Cross and Blue Shield of Kansas continuously monitors the pharmacy landscape to determine the best course of care for members
E., Pavo, I., Lukashevich, V., Kozlovitski, D., Dahl, D.,
Call us at 703-642-6633 today to book your consultation to learn more!
Clinical Trials Semaglutide has demonstrated impressive efficacy in promoting weight loss
Its not just about body fat
Downregulation of YAP Activity restricts P53 hyperactivation to Promote Cell Survival in Confinement